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B-cell-specific expression of the immunoglobulin kappa light-chain (Igc) gene is in part accomplished by
negative regulatory influences. Here we describe a new negatively acting element (termed KNE) immediately
upstream of the NF-cB-binding site in the Igc intronic enhancer. The 27-bp KNE sequence is conserved in the
corresponding positions in the rabbit and human IgK genes, and the human KNE homolog was shown to have
a similar negative regulatory activity. Data base searches using the mouse KNE sequence revealed a striking
homology to murine Bi repetitive sequences. A sequence homologous to KNE and B1 was also noted in a
previously identified silencer element in the murine T-cell receptor a locus. The homologous T-cell receptor a
locus sequence, but notably not a corresponding 27-bp Bi consensus sequence, showed a negative regulatory
potential similar to that of KNE. The negative effect of KNE by itself was not cell type specific but became so
when paired with its 5'-flanking sequence in the Igc enhancer. A short (30-bp) fragment upstream of KNE
(termed KBS) was found to be necessary and sufficient for abolishing the negative effect ofKNE in B cells. Point
mutations in a T-rich motif within the cBS sequence allowed the transcriptional repression by KNE to be
evident in B cells as well as other cells. As suggested by this cell-independent negative activity, proteins binding
to the mouse and human KNE sequences were identified in all cell types tested.
The regulation of the immunoglobulin K light-chain (IgK)
gene during B-cell development involves the IgK promoter
and two distinct enhancer elements (for a review, see
reference 11). The better characterized of the two IgK
enhancers resides in the intron between the J and C regions,
whereas the more recently identified 3' enhancer is located
several kilobases downstream of the IgK constant region.
Both of these enhancers contain multiple sites for positive
and negative regulation.
Some of the B-cell-specific activity of the IgK intronic
enhancer can be attributed to the cell type specificity of the
key positive regulator NF-KB (10), which becomes constitu-
tively activated in the nuclei of maturing B cells (2). Al-
though NF-KB can be activated from its inactive cytosolic
form in most other cell types, this activation does not lead to
an increased IgK intronic enhancer activity in non-B cells,
such as T cells (17). Some of this cell type-specific negative
regulation has been mapped to a 200-bp fragment upstream
of the NF-KB-binding site (16). Removal of these sequences
results in the inducibility of the IgK enhancer by NF-KB site
activators in non-B cells.
Here we show that another component of negative regu-
lation at this locus can be ascribed to a short sequence
immediately 5' of the KB site in the IgK intronic enhancer.
The activity of this element is not cell specific but becomes
so when paired with a neighboring short sequence. The
minimal negative element, but none of its flanking sequences
in the IgK intronic enhancer, is closely related to the murine
Bi repeat elements. Our experiments with a similar se-
quence from the T-cell receptor a locus (TCRa) enhancer
indicate that Bl-like sequences in other genetic contexts
may be generally important as negative regulatory elements.
Finally, we identify specific KNE-binding factors in nuclear
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extracts from several cells and show that this binding activ-
ity correlates with the transcriptional repression by KNE.
MATERUILS AND METHODS
Plasmid constructs. The pfLUC plasmid was constructed
by cloning the mousefos promoter sequences (-56 to +109;
from plasmid A56-fos-CAT; 6) to plasmid pBL-KS, made by
inserting a new cloning site into the pBL vector (kindly
provided by David Cobrinik, Whitehead Institute, Cam-
bridge, Mass.) with the Photinus pyralis luciferase coding
sequence in a pBluescript-based plasmid.
The NF-KB-driven plasmid pBIIX was constructed by
inserting a synthetic fragment with two copies of the se-
quence ACA GAG GGG ACT TTC CGA GAG separated by
four nucleotides (ATCT) in front of mouse fos promoter in
plasmid pfLUC. The IgK fragments with different 5' ends
were polymerase chain reaction (PCR) amplified from an IgK
J-C region-containing plasmid and cloned into a SacI site
immediately upstream of the first KB-binding site in pBIIX.
Thus, all the resulting inserts had identical 3' ends with IgK
sequence extending to position 3934 and had mutated resi-
dues at positions 3927 and 3929 (C to G and T to G,
respectively) to create the Sacl site (see Fig. 3A for se-
quence in this region). Since the functionally critical region
of the IgK negative element was localized immediately 5' of
the introduced SacI site, we also constructed a plasmid in
which the IgK insert shared its 5' end with the 192-bp
fragment but had a perfect wild-type sequence extending all
the way to (and including) the vB motif. No difference in the
negative regulatory potential was observed between this
construct and the SacI site-containing 192-bp IgK fragment
construct. The plasmids carrying the 192-bp IgK fragment
with point mutations (192L, 192R, and 192M) or deletions
(192D) in the B1 homology region were constructed similarly
but with longer 3' PCR primers including the corresponding
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base changes. The 27-bp KNE fragment-containing plasmid,
as well as the other constructs with short inserted sequences
used in the experiments shown in Fig. 2 and 3, were
constructed by cloning corresponding synthetic double-
stranded oligonucleotides into pBIIX or pfLUC. The mutant
96-bp IgK fragment (in construct 96B in Fig. 1A) was made
by joining two partially overlapping PCR fragments (each
having the desired point mutations in their overlapping 3'
and 5' ends) by a second PCR with the same primers used to
amplify the 96-bp wild-type IgK fragment. All the constructs
were verified by sequencing the region of the inserted
fragment and the KB motifs.
Cells, transfections, and reporter expression assays. Ap-
proximately 5 x 106 cells were used for each transfection,
which was done as described previously (7). The luciferase
assay was performed 38 h after transfection using the
Promega Luciferase Assay System. Phorbol 12-myristate
13-acetate (PMA), lipopolysaccharide, and forskolin used to
stimulate the cells were purchased from Sigma. The HeLa,
Jurkat, EL-4, BW5147, S194, P3X, PD31, 70Z/3, 22D6, and
NFS-5 cell lines and references for them can be found from
the American Type Culture Collection catalog. The first two
are human cell lines, whereas the rest are of murine origin.
The efficiency of each transfection was monitored by a
cotransfected cytomegalovirus enhancer-driven lacZ con-
struct kindly provided by Garry Nolan from our laboratory.
The lysates used for luciferase assay were also tested for their
,B-galactosidase activity by using o-nitrophenyl-p-D-galacto-
pyranoside (ONPG; Sigma) as a chromogenic substrate, and
samples showing more than 25% variation in their optical
densities at 420 nm were excluded.
Gel mobility shift assays. Nuclear extracts were prepared
as previously described (3). The oligonucleotide probes were
synthesized with an Applied Biosystems 392 DNA/RNA
Synthesizer and their nucleotide sequences were as follows:
mouse KNE, 5'-ACC TCT GTC ACC CAA GAG TTG GGA
GCT CAG CTC CCAACT CTl GGG TGA CAG AGG T-3';
mutant mouse cNE, 5'-ACC TCT GTTh_TC CAA GAG
TACLIGA GCT CAG CTC AGT ACT CTl GGA CAA CAG
AGG T-3' (mutations in the sense-strand region of the
oligonucleotide underlined); and human KNE, 5'-TGC TCT
CCC ACC CAA CGG GTG GGA GCT CAG CTC CCA CCC
GTT GGG TGG GAG AGC A-3'. The oligonucleotides were
purified from an acrylamide gel, 100 ng of each oligonucle-
otide was end labeled, extracted twice with phenol-chloro-
form, diluted to 2 ml with TE (Tris-EDTA), boiled for 3 min,
and allowed to sit at room temperature to allow self-anneal-
ing. The labeled probes were concentrated and separated
from unincorporated radioactivity by three rounds of micro-
concentration using Centricon-10 columns (Amicon). Nu-
clear extract (10 ,ug) was incubated for 40 min at room
temperature with 0.5 ng of probe (corresponding to 3 x 105
cpm) in a solution containing 10 mM Tris (pH 7.5), 50 mM
NaCl, 5% glycerol, 1 mM EDTA, and 1 mM dithiothreitol
together with 2 ,ug of poly(dI dC) and 200 ng of an unrelated
short double-stranded oligonucleotide in a final reaction
volume of 20 ,ul. In some reaction mixtures, 50 ng of a
specific competing self-annealed oligonucleotide was also
added. The sequences of the TCRa and consensus Bi
competitor fragments are given in Fig. 2B. The complexes
were electrophoresed in gels containing 4% acrylamide,
0.25 x TBE (Tris-borate-EDTA) and 10% glycerol at 4°C for
7 h at 10 V/cm.
RESULTS
Characterization of the IgK negative element. To analyze
the negative regulatory region in the IgK intronic enhancer, a
192-bp fragment upstream of the KB site was cloned into a
luciferase reporter plasmid (pBIIX) in which transcription
was stimulated by two copies of the murine IgK NF-KB-
binding site in front of a minimalfos promoter (see Materials
and Methods). This 192-bp fragment included most of the IgK
intronic sequences used in a previous study (16) but ex-
tended closer to the KB site at the 3' terminus. Other
modifications to the previous study included the use of a
smaller promoter to amplify the importance of the enhancer,
and addition of an upstream polyadenylation site to block
any read-through transcription initiated from the vector
sequences.
We subjected this 192-bp IgK fragment to a series of
deletions and point mutations (Fig. 1A). Luciferase activity
of these constructs was measured after transient transfection
into cells representing B-cell and non-B-cell lineages. In all
experiments, a cotransfected heterologous reporter con-
struct was used as an internal control for transfection
efficiency and cell viability (see Materials and Methods).
After 4-h stimulation with 100 nM PMA or 2 ,ug of
phytohemagglutinin per ml, agents known to induce NF-KB
activity, the vector containing two copies of the NF-KB-
binding site showed strong activation in T cells (Jurkat and
EL-4), and in nonlymphoid cells (HeLa) (Fig. 1A and data
not shown). In contrast, the luciferase activity produced by
a corresponding construct lacking the KB sites and having
only the minimal mousefos promoter (pfLUC) was less than
5% of this activity, indicating that we are indeed measuring
transcription stimulated via the NF-KB-binding sites. As
expected, high levels of luciferase activity were seen in S194
plasmacytoma cells transfected with pBIIX without the
addition of exogenous NF-KB activators.
When the 192-bp IgK fragment was introduced upstream of
the two KB sites in the pBIIX vector, we found that the
PMA-stimulated luciferase expression of non-B cells trans-
fected with this construct was reduced to one-third of that of
cells transfected with the parental vector pBIIX (shown in
Fig. 1A for Jurkat cells). In contrast, in mature B cells (S194
or P3X), the 192-bp IgK fragment had a marginal or no effect
on NF-KB-driven transcription. Also, no negative effect on
PMA-stimulated luciferase expression by the 192-bp IgK
fragment was observed in any pre-B-cell lines tested (22D6,
PD31, 70Z/3, and NFS-5); instead, slightly higher luciferase
activities were observed than in pBIIX-transfected cells
(22D6 cells [Fig. 1A]).
Analysis of the effect of successive 5' deletions of this
192-bp fragment indicated that its negative effect could be
restricted to a 27-bp sequence (referred to as KNE) immedi-
ately upstream of the NF-KB-binding site in the IgK intronic
enhancer (Fig. 1A; see also Fig. 3A). When an even shorter
17-bp fragment was tested, the negative effect was weaker,
but this construct still showed consistently -50% lower
transcriptional activity than the pBIIX construct. A multi-
mer consisting of three copies of this 17-bp sequence had a
negative effect slightly stronger than any of the monomeric
IgK fragments (construct 3 x 17 in Fig. 1A).
We further examined the KNE sequence requirements by
introducing mutations into the 192-bp IgK fragment within
the 17-bp region indicated above (Fig. 1B). We found that
the negative effect of the 192-bp fragment could be severely
compromised by mutating only four (192L) or three (192R)
nucleotides at either end of this 17-bp semipalindromic
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FIG. 1. Mutational analysis of a cell type-specific negative element in the IgK intronic enhancer. (A) The locations of the subcloned 192-bp
fragment upstream of the NF-KB-binding site and the E-boxes within the murine IgK enhancer are illustrated schematically at the top of the
figure. Different IgK fragments from this region were tested for their ability to downregulate transcription stimulated by two copies of the
NF-KB-binding site (shaded ovals) that directed transcription from a minimal (-56 to 109)fos promoter (f) in plasmid pBIIX. The 192-bp IgK
fragment and different 5' truncated versions of this fragment were cloned 5' of two KB sites in plasmid pBIIX. The lengths of the truncated
IgK fragments that all share a common 3' end (IgK residue 3926) are indicated to the left of each vector. Vector 96B is a mutated version of
construct 96 and contains the GCGCGC sequence instead of TTCGTT in the position indicated by the dark box. Luciferase expression was
then measured in PMA-stimulated T cells (Jurkat) and pre-B cells (22D6) as well as in unstimulated B cells (S194) transiently transfected with
these vectors. In all experiments, the luciferase activity produced by the parental pBIIX construct was normalized to 100%, and the activities
of the other constructs (+ standard deviation) were expressed relative to this. The number of independent experiments performed with each
construct is indicated in the parentheses. (B) Effects of point mutations in the 3' region of the 192-bp IgK fragment on transcriptional
repression in PMA-stimulated Jurkat cells. The nucleotide sequence of the parental 192 construct within the indicated 17-bp region is shown
on the top line. The specific nucleotide substitutions in the derived constructs 192L, 192R, and 192M are underlined, and the deleted
nucleotides in the 192D construct are indicated by dashes. Luciferase expression of these vectors is indicated relative to that of the pBIIX
vector, as described above. LUC, luciferase.
sequence, confirming the functional importance of this re-
gion, as indicated by our deletion studies. The negative
effect of the 192-bp fragment was also affected by deletion of
the three nucleotides, GAG, in the middle of this region
(192D), but not by changing these residues to ATA (192M),
suggesting that not every residue within this 17-bp region is
critical as long as a correct nucleotide spacing is conserved.
Some residual negative effect remained in all of these 192-bp
fragments, as was the case when the whole 17-bp region was
changed to an unrelated sequence (not shown), indicating
some contribution of the more 5' sequences, presumably the
CT-rich region present in the 27-bp fragment but not in the
17-bp fragment shown in Fig. 1A.
Pierce et al. (16) defined a broadly localized negative effect
in the IgK enhancer region upstream of the KB site. In our
constructs, a negative activity is distinctly localized to a
region that was truncated and therefore probably not active
in the fragment studied by Pierce et al. (16). Conversely, we
saw little or no regulatory activity in the IgK region upstream
of the KNE. The negative effect that we have mapped is also
position dependent, because this activity was completely
abolished by a 260-bp nonspecific pUC-derived fragment
inserted between the KNE- and NF-KB-binding sites (not
shown). We are uncertain why the activity defined in the
earlier experiments was not evident in the present experi-
mental set-up, but we have gone on to define the new activity
A.
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FIG. 2. Comparative analysis of sequences homologous to the
murine KNE. (A) Alignment of the corresponding human and rabbit
IgK sequences with the 27-bp murine KNE. The nucleotide residues
conserved in all three species are shown in boldface type. (B)
Comparison of the murine KNE and TCRSIL2 fragments and a
murine Bi element consensus (cBl) sequences. (C) Analysis of
transcriptional effects of the mouse KNE and other Bl-homologous
sequences. Twenty-seven-base-pair fragments corresponding to
mouse and human KNE, mouse TCRSIL2, and the consensus Bi
element shown in Fig. 2B were introduced upstream of the KB sites
in plasmid pBIIX as in Fig. 1A and tested for their effect on
NF-KB-stimulated luciferase expression in PMA-stimulated Jurkat
cells (human and mouse KNE) or unstimulated S194 cells (TCRSIL2
and cBl).
because it has properties that suggest it has general signifi-
cance.
To study whether the negative effect of the KNE was
restricted to NF-KB, we precisely replaced the KB sites in
the pBIIX construct and its derivative carrying the 192-bp
IgK fragment (Fig. 1A) by two copies of the cyclic AMP
responsive element consensus sequence (TGACGTCA [19])
and measured the forskolin-stimulated and unstimulated
luciferase expression of these constructs in Jurkat cells. In
both cases, an approximately threefold-lower luciferase ac-
tivity was produced by the 192-bp IgK fragment-containing
vector (not shown). Thus, the negative activity of KNE is not
restricted to NF-KB, but it can downregulate transcription
activated via other binding sites.
A sequence homologous to the murine KNE is also present
adjacent to the KB site in the human IgK intronic enhancer
(Fig. 2A), suggesting that it might have a similar negative
regulatory role. We tested this directly by introducing the
human 27-bp KNE sequence into the pBIIX reporter con-
struct and found that this element could indeed interfere with
NF-KB-driven transcription and have a negative effect cor-
responding to that of the mouse KNE (Fig. 2C). The conser-
vation of KNE between the mouse, human, and rabbit
sequences highlights the significance of this element and
points to the importance of the specific residues indicated by
our mutagenesis studies.
KNE is homologous to the Bi repeat element. When we
screened the GenBank data base using the 27-bp murine
KNE sequence, a large number of almost perfect alignments
was found. This turned out to be due to the homology of
KNE to the mouse Bi short repetitive sequences and their
primate Alu counterparts (Fig. 2B). This homology was
shared only by the KNE region and did not extend to its
flanking sequences in the IgK enhancer.
Interestingly, we noted that a Bl-homologous sequence
corresponding to KNE is also present in a previously char-
acterized silencer element, TCRSIL2 (24), in the mouse
T-cell receptor a gene locus (Fig. 2B). We tested this 27-bp
TCRot fragment in our KB-driven reporter gene system and
found it to have a negative transcriptional effect similar to
that of KNE (Fig. 2C). The plasmid constructs used in these
experiments had the TCRa sequence inserted in an orienta-
tion opposite to that of KNE (which was in the sense
orientation). Both TCRa and IgK 27-bp fragments were,
however, able to repress transcription in either orientation.
We then tested a 27-bp B1 consensus fragment (cB1 in Fig.
2B) corresponding to the single most prevalent sequence in
this region of Bi elements (on the basis of our GenBank data
base searches and references 12 and 18). However, no
negative effect on NF-KB-stimulated transcription was ob-
served with this consensus Bi fragment, suggesting that not
all Bi repeats have negative regulatory potential. The data
shown in Fig. 2C on the transcriptional effects of the human
and mouse 27-bp KNE fragments were obtained from PMA-
stimulated Jurkat cells, and the data on the 27-bp TCRax or
consensus Bi fragments were obtained from S194 cells.
However, as shown for the mouse KNE in Fig. 1A, none of
these short Bl-homologous fragments showed cell type
specificity in their action, and the negative effects of the
mouse TCRa fragment and human KNE were equally evi-
dent in T cells and B cells (data not shown).
Inactivation of KNE in B cells by an upstream element.
When the series of constructs containing differentially 5'
deleted versions of the 192-IgK fragment were tested in S194
cells (Fig. 1A), we found that disruption of the KNE se-
quence from its upstream flanking region resulted in an
activation of its negative potential in B cells (Fig. 1A). In
contrast to the 192-bp IgK fragment, the 27-bp KNE fragment
could repress transcription in all cell types tested, including
B cells. The presence of only 30 bp of IgK sequences
upstream of the KNE, however, was sufficient to restore the
cell type specificity of the KNE, since no negative effect was
observed for the 57-bp fragment when tested in S194 cells
(Fig. 1A). Therefore, this 30-bp region is a critical determi-
nant of the cell type specificity of KNE. The nucleotide
sequence of this 30-bp fragment (referred to as KBS for IgK
B-cell specificity) is shown in Fig. 3A. The KBS sequence
contains two copies of the T-rich motif GTTIT separated by
a C residue. Disruption of this region of the iBS element in
the reporter construct with a 96-bp IgK fragment by a
TTCGTT-to-GCGCGC mutation activated the negative po-
tential of this fragment in S194 cells, rendering it as potent a
negative element in B cells as in non-B cells (compare
constructs 96 and 96B in Fig. 1A).
To test whether the KBS-mediated B-cell-specific allevia-
tion of the negative regulation by KNE could be due to an
independent positive transcriptional effect by KBS, we intro-
duced two copies of the KBS sequence in front of the
minimal fos promoter in the pfLUC luciferase construct.
Luciferase expression of the resulting plasmid pKBS was
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FIG. 3. Cell-type-specific enhancement of transcriptional activation by NF-KB via a T-rich sequence (KBS) from the IgK intronic enhancer.
(A) Nucleotide sequence of the murine IgK gene from positions 3880 to 3952. The bars indicate the exact sequences of the KBS and KcB motifs
introduced in the fos promoter-luciferase reporter constructs. The 27-bp KNE sequence is also indicated to illustrate the close proximity of
these elements in the IgK intronic enhancer. The core IgK NF-KB-binding site is indicated by boldface type. (B) The vectors in the indicated
transfection experiments contained two tandem copies of the KBS sequence (shown in panel A) upstream of a minimal fos promoter either
alone (pKcBS) or in combination with two copies of the IgK KB motif (pKBS-KB). The luciferase activities in transiently transfected unstimulated
B cells (5194) cells or PMA-stimulated T cells (Jurkat) are expressed relative to the activity of a construct containing only the minimalfos
promoter (pfLUC). Separate scales for the relative transcriptional activity are given for the two cell lines. The mean values from three or more
independent experiments and their standard deviations are shown.
then compared with that of pfLUC in B cells and non-B
cells. No significant transcriptional stimulation was ob-
served in either cell type, suggesting that the KBS element by
itself has no transcriptional activation potential.
However, when the two copies of the KBS sequence were
cloned 5' of the NF-KB binding sites in plasmid pBIIX
(resulting in plasmid pKBS-KB), a marked enhancement in
transcription was observed in B cells (Fig. 3B). The strong
transcriptional activation by two murine IgK KB sites in S194
cells was further increased two- to threefold by the addi-
tional tandem KBS element. In contrast, no such potentiation
of the NF-KB-activated transcription by KBS was seen in
PMA-stimulated Jurkat cells; instead, less luciferase was
expressed in these cells by the pcBS-KB plasmid than by
pBIIX (Fig. 3B). A sequence homologous to the mouse KBS
element is also present adjacent to the KNE element in the
human kappa enhancer. A similar B-cell-specific enhance-
ment of transcriptional activation via the IgK KB site was also
observed with the human KBS sequence (data not shown).
These data suggest a role for the KBS element as a cell
type-specific modulator of transcriptional activation via the
NF-KB-binding site within the IgK intronic enhancer. Thus,
combined influences by these three closely positioned bind-
ing sites (KBS, KNE, and KB) appears to create a composite
enhancer element whose activity is regulated by NF-KB but
is mainly restricted to the B-cell lineage.
Sequence-specific nuclear factor binding to KNE correlates
with its negative regulatory potential. To characterize factors
mediating the negative transcriptional effect of the KNE, we
prepared nuclear extracts from various B-cell and non-B-cell
lines and tested them for specific binding to the KNE
sequence in gel retardation assays. In agreement with the
ubiquitous activity of KNE, a specific complex binding to the
mouse KNE probe was detected in mouse (S194 and 22D6)
and human (Jurkat and HeLa) cell lines regardless of their
lineage of differentiation (complex A in the left panel in Fig.
4; also data not shown). The specificity of DNA binding by
complex A was strongly suggested by the experiments
utilizing different unlabeled competitor binding sites and a
mutated version of the KNE probe (discussed below). The
binding of complex A was not very strong; this binding
became evident only when glycerol was added to the mobil-
ity shift gels to stabilize the binding and increased when
electrophoresis was carried out at 4°C. Under these condi-
tions, an additional slower migrating specific complex was
also observed in HeLa cells (A' in Fig. 4, left panel). This
complex was not detected in nuclear extracts from other
human or mouse cell lines. Complex A' could therefore be
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FIG. 4. Specific binding of nuclear factors to the mouse and human KNE sequences. Nuclear extracts from cells representing non-B (HeLa
[human carcinoma cell line]) and B-cell lineages (22D6; v-Abl-transformed mouse pre-B-cell line) were tested for factors that could specifically
bind to mouse and human (hu) KNE probes, as well as a mutant mouse and human KNE probes (*) with changes in nucleotide residues critical
for transcriptional repression by the murine KNE sequence. In some lanes, a 100-fold excess of the indicated unlabeled competitor was also
included in the binding reaction mixture. In lanes labeled -, no specific competitor was used. The details of the assay and the sequences of
the oligonucleotide probes used are specified in the Materials and Methods. Complexes specifically interacting with the mouse (A and A') and
human (B) KNE sequences are indicated by arrows.
due to a cell-type-restricted KNE-binding factor but more
likely reflects a higher quality of the nuclear extracts pre-
pared from HeLa cells. Although there is no direct evidence
that the constituents of complexes A and A' are related, we
will refer to both of them as mBl-NF (for murine Bl-binding
nuclear factor).
To test whether binding of mBl-NF to the 27-bp KNE
element correlated with its transcriptional repression poten-
tial, we prepared a mutant probe (mouse KNE* [lanes 1 and
11 in Fig. 4]) in which residues CAC and TGG were changed
to TGT and ACT, respectively (for details, see Materials and
Methods). On the basis of our mutagenesis studies (Fig. 1B),
these changes should abolish transcriptional repression by
mouse KNE and, therefore, presumably disrupt binding of
any functionally relevant negative factors. No mBl-NF
binding was observed with this mutant version of the KNE
sequence, indicated by the complete absence of complexes
A and A' in Fig. 4 (compare lanes 1 and 2 and lanes 11 and
12). Identical arrays of complexes binding nonspecifically to
both the mutant and wild-type probe highlighted the speci-
ficity of the loss of mB1-NF interaction with the mutant KNE
probe. In agreement with these results, a 100-fold excess of
the mutant KNE fragment was unable to abolish B1-NF
binding to the wild-type KNE probe. In contrast, under the
same conditions, a 100-fold excess of the wild-type KNE
competitor completely abolished the B1-NF complex (Fig.
4). These data confirm that the mBl-NF complex binds
specifically to the mouse KNE sequence and show that this
interaction is dependent on the nucleotide residues critical
for the negative regulatory potential of KNE.
These results prompted us to use other fragments homol-
ogous to KNE and Bi and previously tested for their tran-
scriptional regulatory potential as specific competitors for
B1-NF binding to the mouse KNE probe. It is striking that
the KNE-like fragment from the TCRot silencer, which had a
negative regulatory potential comparable to that of KNE,
was also able to efficiently abolish mBl-NF binding to the
KNE probe (Fig. 4, lanes 5 and 15). In contrast, despite its
close sequence similarity, the corresponding 27-bp mouse
Bi repeat consensus fragment failed to abolish mBl-NF
binding (lanes 6 and 16), which correlated with its lack of
negative regulatory potential in reporter gene assays (Fig.
2C). These results substantiate the significance of the
mBl-NF as a mediator of the negative regulation by KNE
and suggest a role for it in negative regulation by a subset of
other Bl-homologous sequences dispersed in the mouse
genome, such as the Bi homology region in the TCRa
silencer.
The negatively acting human KNE homolog, however, did
not abolish binding of mBl-NF to the mouse KNE probe in
nuclear extracts either from mouse or human cell lines (Fig.
4, lanes 7 and 17). In order to understand this finding, we
prepared a similar mobility shift probe corresponding to the
human KNE sequence. A single specific binding complex
was observed by using the human KNE probe in mouse and
human cell lines (complex B in Fig. 4), which had an
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electrophoretic mobility between those of the mBl-NF com-
plexes (A and A'). We will refer to this human KNE-specific
complex as hBl-NF. To study the relationship of complexes
A and B, we prepared a mutant human KNE probe (hKNE*)
with the same mutations that prevented the binding of
mBl-NF to the mouse KNE sequence. No binding of com-
plex B was observed with this mutant probe (Fig. 4, right
panel). Also, 100-fold excess of unlabeled human KNE*
fragment failed to abolish binding of complex B to the human
KNE probe.
Thus, distinct factors, present in mouse and human cells,
appear to be involved in complexes with the mouse and
human KNE sequences in vitro. These factors have similar
but distinct specificities in their binding to DNA. The same
nucleotide residues that were found to be critical for the
negative function of mouse KNE were also necessary for
binding of both mBl-NF and hBl-NF, yet the mouse and
human KNE sequences did not cross-compete for their
binding to these factors. Thus, mBl-NF and hBl-NF could
be distinct but related members of a family of nuclear
proteins. Studies examining molecular characterization of
the constituents of the mB1-NF and hB1-NF complexes will
be needed to clarify their role and mode of action in
transcriptional repression.
DISCUSSION
In this study, we have identified a previously unrecog-
nized short negative element (KNE) close to the NF-KB-
binding site in the IgK intronic enhancer. Computer analysis
of the KNE sequence revealed a striking homology to the
murine Bi repetitive element of the short interspersed repet-
itive element superfamily (see below). Nuclear factors spe-
cifically binding to KNE were identified and termed B1-NF.
Functional significance of the B1-NF complex was sup-
ported by mutagenesis and binding site competition studies
which established a strong correlation between B1-NF bind-
ing to KNE in vitro and transcriptional repression in vivo.
Further characterization of B1-NF will be necessary to
uncover the molecular mechanisms involved in the tran-
scriptional repression by KNE and other similar elements.
The cell type specificity of KNE was found to be deter-
mined by a short element, termed KBS, immediately up-
stream of KNE in the IgK enhancer. Disruption of the KBS
sequence allowed transcriptional repression by KNE to be
evident in B cells. When analyzed separately from KNE, the
KBS sequence was able to cause a B-cell-specific enhance-
ment of transcriptional stimulation via adjacent NF-KB-
binding sites but by itself could not mediate transcriptional
activation. In these properties, KBS is reminiscent of the
sequence that binds the high-mobility-group protein-related
lymphoid enhancer factor 1, a protein that bends DNA and
potentiates the activity of other factors while being inactive
on its own (5).
Nelms and collaborators (14, 15) have previously studied
nuclear factors binding to the human and mouse IgK enhanc-
ers, using probes including the KBS sequences described
here. They concluded that the human sequence is a func-
tional octamer-binding site, whereas the corresponding
mouse sequence instead binds another nuclear factor re-
ferred to as KBF-A. Our gel shift experiments using mouse
and human KBS probes (20a) are consistent with their
findings. However, neither the predominantly B-cell-specific
Oct-2 protein nor KBF-A seems likely to be responsible for
the in vivo effect of the KBS element. First, KBF-A can be
detected only in stimulated pre-B cells, but not in more
mature B cells (14, 20a). Second, comparison of KBS activity
in v-Abl-transformed pre-B cells derived from Oct-2-'- mice
or their wild-type littermates did not suggest a role for Oct-2
protein in the function of mouse or human KBS elements
(unpublished results in collaboration with Lynn Corcoran).
Nevertheless, these studies support an important B-cell-
specific regulatory role for the KBS element and encourage
further studies to characterize putative factors with which it
interacts.
Our reporter transfection studies indicate that KNE can
eliminate about two-thirds of the transcriptional activation
via an adjacent IgK KB site. A functional KB site is crucial for
the transcriptional activity of the IgK intronic enhancer (10),
suggesting an important role for KNE in repressing IgK
expression in non-B cells. However, it is presently not
possible to estimate the magnitude of the KNE effect in its
natural context in the IgK enhancer. Pierce et al. (16) have
previously shown that sequences upstream of the region we
have defined can have a strong negative effect in a slightly
different experimental context. Thus, it is likely that KNE is
only one element involved in keeping the IgK gene silent until
the moment in B-cell development when it is activated.
The sequence homology revealed between KNE and the
Bi family of genomic repeat elements was a surprising
finding and may have important implications. A complete Bi
element is typically -140 bp long (23); therefore, the KNE
sequence only represents a part of such an element. Its high
homology over 26 bp, however, strongly implies that its
evolutionary origin is from a Bl-like repeat. The presence of
a homologous KNE sequence in the corresponding positions
in the human and rabbit IgK J-C intronic enhancers (Fig. 2A)
supports the functional significance of KNE and suggests that
this sequence may have evolved from an archaic Bi or
Alu-like element and then suffered a deletion some time
before these species diverged in evolution.
The idea that Bi elements may have a widespread role in
the negative control of gene expression was strongly sup-
ported by the finding that a sequence homologous to KNE
and Bi is also shared by another previously identified
negative element, namely, TCRSIL2, which is involved in
down-regulation of TCR(x expression in cells other than
oa3-lineage T cells (24). The Bl-like sequence in TCRSIL2 is
a more typical Bi element than KNE is, which suggests a
more recent evolutionary origin. Therefore, the ability of the
27-bp KNE- or Bl-like TCRSIL2 fragment to negatively
regulate reporter gene transcription and to abolish binding of
mBl-NF to the KNE sequence demonstrates that the Bi
homology of the KNE sequence is functionally relevant.
Another 27-bp fragment, corresponding to the most preva-
lent (consensus) sequence in this region of the Bi elements,
however, did not show any negative regulatory activity in
our test system and it did not compete with the KNE probe
for mBl-NF binding. Thus, it appears that only certain
variants of the Bl-like sequences may acquire a negative
regulatory function.
A role for some other highly repeated sequences in the
negative control of transcription has been suggested by
previous studies. The silencer element in the rat insulin 1
locus was identified as a member of a rat long interspersed
repetitive sequence family (9). One of the three identified
chicken lysozyme silencer elements was found to consist of
sequences homologous to the chicken middle repetitive
sequence element CR1 (1). Also, although the Alu sequences
have not been indicated in negative regulation of any specific
genes, their potential for transcriptional repression has been
suggested (20, 21).
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Bi sequences, as well as many of the other highly repeated
genomic sequences, are thought to represent retrotrans-
posons, DNA elements which can be copied into new
positions in the genome through RNA intermediates. Evo-
lutionary characterization, as well as rare studies in real time
(4), has confirmed that some of repeated sequences, includ-
ing the Alu elements (13, 22), continue to retrotranspose.
The notion that these sequences, after perhaps a small
number of mutations, can play a physiological role has been
an attractive one for many years, but has received little
support (recently reviewed by Howard and Sakamoto [8]).
Involvement of a mobile DNA element in transcriptional
regulation would allow alterations in gene expression to
occur with great flexibility, ease, and speed over evolution-
ary time.
It is tempting to speculate that in addition to IgK and TCRao
enhancers, Bl-like sequences could be widely used as ver-
satile building blocks that confer a negative transcriptional
effect onto a variety of different cell type- and differentia-
tion-specific enhancers. A large number of the murine and
primate genes so far sequenced and characterized contain
Bi- and Alu-like sequences in positions which could imply
regulatory significance (20a). Further studies addressing the
detailed sequence and spatial requirements functionally crit-
ical for Bl-like negative elements should help predicting
which ones are likely to be involved in the control of gene
expression.
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